Wellington Partners and HBM Healthcare Investments have led a €22m financing round for Germany-based biopharmaceutical company Adrenomed.
Wellington Partners and HBM Healthcare Investments have led a €22m financing round for Germany-based biopharmaceutical company Adrenomed.